Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 2/20 | 0.79 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 3/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.75 |
| ▸ | HTT | P42858 | 1/20 | 0.75 |
| ▸ | RAB9A | P51151 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.71 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.60 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.60 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.60 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.60 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22065210 | 0.94 | MAPT (0.81) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL4286068 | 0.90 | MAPT (0.94) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL4656855 | 0.87 | MAPT (0.78) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL12764063 | 0.86 | MEN1 (1.00) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL22065212 | 0.86 | PTGS1 (0.80) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL20073524 | 0.86 | MAPT (0.81) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL15603515 | 0.86 | MAPT (0.81) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL4517587 | 0.85 | LMNA (1.00) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL30739929 | 0.85 | LMNA (1.00) | KCNK3KCNK9MAPTMEN1KMT2A | |
| SCHEMBL22024848 | 0.85 | KCNK3 (0.73) | KCNK3KCNK9MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1846532-B1 | ENERGIZED FLUIDS AND METHODS OF USE THEREOF | SCHLUMBERGER SERVICES PETROL (FR) | 2013-09-18 | — | — | EP | claimed |
| US-8207094-B2 | fluid compositions used in treating a subterranean formation. In particular, the invention is aqueous wellbore treatment compositions which are foams containing a viscosifying agent, a foam extender, a gas component, and a surfactant, as well as methods of forming such fluids, and uses thereof. | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2012-06-26 | — | — | US | claimed |
| CN-101379160-B | Stabilized and freeze-protected polymer drag reducing agent suspensions | BAKER HUGHES INC | 2012-04-25 | — | — | CN | claimed |
| US-7781380-B2 | Methods of treating subterranean formations with heteropolysaccharides based fluids | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2010-08-24 | — | — | US | claimed |
| US-7776796-B2 | Methods of treating wellbores with recyclable fluids | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2010-08-17 | — | — | US | claimed |
| EP-1999225-B1 | METHODS OF TREATING WELLBORES WITH RECYCLABLE FLUIDS | SCHLUMBERGER SERVICES PETROL (FR) | 2010-05-12 | — | — | EP | claimed |
| CN-101379160-A | Stabilized and freeze-protected polymer drag reducing agent suspensions | BAKER HUGHES INC (US) | 2009-03-04 | — | — | CN | claimed |
| US-7494957-B2 | Energized fluids and methods of use thereof | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2009-02-24 | — | — | US | claimed |
| EP-1994111-A2 | STABILIZED AND FREEZE-PROTECTED POLYMER DRAG REDUCING AGENT SUSPENSIONS | Baker Hughes Incorporated (US) | 2008-11-26 | — | — | EP | claimed |
| US-20080269080-A1 | Wellbore Treatment Compositions Containing Foam Extenders and Methods of Use Thereof | HUTCHINS RICHARD D | 2008-10-30 | — | — | US | claimed |
| US-20080026957-A1 | Treatment and Production of Subterranean Formations with Heteropolysaccharides | SCHLUMBERGER TECHNOLOGY CORPORATION | 2008-01-31 | — | — | US | claimed |
| US-20080004187-A1 | Energized Fluids and Methods of Use Thereof | PENA ALEJANDRO | 2008-01-03 | — | — | US | claimed |
| US-20070215355-A1 | Methods of Treating Wellbores with Recyclable Fluids | SCHLUMBERGER TECHNOLOGY CORPORATION | 2007-09-20 | — | — | US | claimed |
| US-20070205392-A1 | Stabilized and Freeze-Protected Polymer Drag Reducing Agent Suspensions | BAKER HUGHES INCORPORATED (US) | 2007-09-06 | — | — | US | claimed |
| WO-2007092510-A2 | STABILIZED AND FREEZE-PROTECTED POLYMER DRAG REDUCING AGENT SUSPENSIONS | BAKER HUGHES INCORPORATED (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070042913-A1 | Wellbore treatment compositions containing foam extenders and methods of use thereof | SCHLUMBERGER TECHNOLOGY CORPORATION | 2007-02-22 | — | — | US | claimed |
| US-20060166837-A1 | Methods of treating subterranean formations with heteropolysaccharides based fluids | SCHLUMBERGER TECHNOLOGY CORPORATION | 2006-07-27 | — | — | US | claimed |
| US-20060166836-A1 | Energized fluids and methods of use thereof | SCHLUMBERGER TECHNOLOGY CORPORATION | 2006-07-27 | — | — | US | claimed |
| US-11352354-B2 | Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof | XIAMEN UNIVERSITY (CN) | 2022-06-07 | — | — | US | disclosed |
| US-20070042913-A1 | Wellbore treatment compositions containing foam extenders and methods of use thereof | SCHLUMBERGER TECHNOLOGY CORPORATION | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352354-B2 | Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof | PIKFYVE, PIK3CA, PIK3C2A | KCNK3 1001/4885KCNK9 1590/4885MAPT 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.